EGFR and cancer: Moreover, the activation of signaling pathways involved in sustaining cancer proliferation, including EGFR, HER2, B-RAF, ERK, mTOR, AKT, and SRC, have been identified in association with ADPKD, accumulating evidence that polycystins may be involved in cancer development and progression [118].